Clinical Microbiology Reviews

Papers
(The H4-Index of Clinical Microbiology Reviews is 40. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Extracutaneous sporotrichosis305
Wild-type distributions of minimum inhibitory concentrations and epidemiological cut-off values—laboratory and clinical utility265
Vaccines and monoclonal antibodies to prevent healthcare-associated bacterial infections164
A Comprehensive Review on the Role of the Gut Microbiome in Human Neurological Disorders160
Transmission of Infections during Cardiopulmonary Resuscitation151
Antibiotic tolerance among clinical isolates: mechanisms, detection, prevalence, and significance126
Erratum for Nyaruaba et al., “Digital PCR Applications in the SARS-CoV-2/COVID-19 Era: a Roadmap for Future Outbreaks”125
Viral infections and pathogenesis of glaucoma: a comprehensive review122
Membrane Technology for Rapid Point-of-Care Diagnostics for Parasitic Neglected Tropical Diseases119
Sensitivity to Vaccines, Therapeutic Antibodies, and Viral Entry Inhibitors and Advances To Counter the SARS-CoV-2 Omicron Variant102
HIV-associated cancers and lymphoproliferative disorders caused by Kaposi sarcoma herpesvirus and Epstein-Barr virus101
Intestinal biofilms: pathophysiological relevance, host defense, and therapeutic opportunities94
Progression of antibiotic resistance in Neisseria meningitidis87
Clostridioides difficile infection: history, epidemiology, risk factors, prevention, clinical manifestations, treatment, and future options83
Review of BCG immunotherapy for bladder cancer82
Henipaviruses: epidemiology, ecology, disease, and the development of vaccines and therapeutics81
Viral Respiratory Pathogens and Lung Injury80
Evolutionary Pathways and Trajectories in Antibiotic Resistance76
Non- faecium non- faecalis enterococci: a review of clinical manifestations, virulence factors, and antimicrobial resistance71
Clonorchiasis and opisthorchiasis: epidemiology, transmission, clinical features, morbidity, diagnosis, treatment, and control70
Neisseria gonorrhoeae vaccines: a contemporary overview69
Congenital Syphilis: a Review of Global Epidemiology64
Bacillus cereus Invasive Infections in Preterm Neonates: an Up-to-Date Review of the Literature59
BCG therapy in bladder cancer and its tumor microenvironment interactions54
Diagnosis, Management, and Future Control of Cholera53
Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease53
Aspergillus terreus Species Complex51
COVID-19 Convalescent Plasma and Clinical Trials: Understanding Conflicting Outcomes50
Rapid and accurate testing for urinary tract infection: new clothes for the emperor50
The mRNA Vaccine Technology Era and the Future Control of Parasitic Infections48
Trained Immunity as a Preventive Measure for Surgical Site Infections47
Harnessing the host response for precision infectious disease diagnosis46
Immunosuppressant imprecision: multidirectional effects on metabolism and microbiome45
Lyme borreliosis in Brazil: a critical review on the Baggio–Yoshinari syndrome (Brazilian Lyme-like disease)45
Agnostic Sequencing for Detection of Viral Pathogens45
Artemisinin-resistant malaria44
Mobile Oxazolidinone Resistance Genes in Gram-Positive and Gram-Negative Bacteria44
Advances in the Microbiology of Stenotrophomonas maltophilia43
2021 Acknowledgment of CMR Reviewers40
Editorial Board40
0.088038921356201